000			01541 a2200457 4500
005			20250512000615.0
264		0	_c19900314
008			199003s 0 0 eng d
022			_a0278-0232
024	7		_a10.1002/hon.2900080107 _2doi
040			_aNLM _beng _cNLM
100	1		_aTucker, J
245	0	0	_aImmunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome. _h[electronic resource]
260			_bHematological oncology _c
300			_a47-58 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal
650	0	4	_aAntigens, CD _xanalysis
650	0	4	_aAntigens, Differentiation _xanalysis
650	0	4	_aAntigens, Differentiation, Myelomonocytic _xanalysis
650	0	4	_aAntigens, Neoplasm _xanalysis
650	0	4	_aHLA-DR Antigens _xanalysis
650	0	4	_aHumans
650	0	4	_aIntegrin alphaXbeta2
650	0	4	_aLeukemia, Myeloid, Acute _xclassification
650	0	4	_aMacrophage-1 Antigen
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
650	0	4	_aReceptors, Leukocyte-Adhesion _xanalysis
650	0	4	_aSurvival Analysis
700	1		_aDorey, E
700	1		_aGregory, W M
700	1		_aSimpson, A P
700	1		_aAmess, J A
700	1		_aLister, T A
700	1		_aHorton, M A
773	0		_tHematological oncology _gvol. 8 _gno. 1 _gp. 47-58
856	4	0	_uhttps://doi.org/10.1002/hon.2900080107 _zAvailable from publisher's website
999			_c2410906 _d2410906